Biomea Fusion, Inc. (BMEA) Corporate Subsidiaries
Biomea Fusion, Inc. (BMEA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BMEA
CIK: 1840439
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMay Yu
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-13 | 8-K | 0001193125-26-420684 | View SEC Doc Filr Page |
| 424B5 | 2026-09-22 | — | 424B5 | 0001193125-26-397909 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | 8-K | 0001193125-26-397870 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335085 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335073 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001193125-26-269470 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001193125-26-269469 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001193125-26-269468 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001193125-26-269465 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | 8-K | 0001193125-26-266687 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001193125-26-217074 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-217037 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-27 | 8-K | 0001193125-26-183710 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-10 | DEF 14A | 0001193125-26-182080 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001193125-26-182038 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 | 0001193125-26-142178 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 | 0001193125-26-142177 | View SEC Doc Filr Page |
| 10-K | 2026-03-24 | 2025-12-31 | 10-K | 0001193125-26-121825 | View SEC Doc Filr Page |
| 8-K | 2026-03-24 | 2026-03-24 | 8-K | 0001193125-26-121811 | View SEC Doc Filr Page |
| 8-K | 2026-02-25 | 2026-02-25 | 8-K | 0001193125-26-068375 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001649553-26-000021 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-12 | — | SCHEDULE 13G Filing | 0001140361-26-004993 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-06 | — | SCHEDULE 13G/A Filing | 0001193125-26-041263 | View SEC Doc Filr Page |
| 5 | 2026-02-06 | 2025-12-31 | 5 | 0001193125-26-041207 | View SEC Doc Filr Page |
| 8-K | 2026-01-14 | 2026-01-14 | 8-K | 0001193125-26-012908 | View SEC Doc Filr Page |